| MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients AD Pardanani, RL Levine, T Lasho, Y Pikman, RA Mesa, M Wadleigh, ... Blood 108 (10), 3472-3476, 2006 | 1326 | 2006 |
| JAK2V617F mutation in essential thrombocythaemia: clinical associations and long‐term prognostic relevance AP Wolanskyj, TL Lasho, SM Schwager, RF McClure, M Wadleigh, SJ Lee, ... British journal of haematology 131 (2), 208-213, 2005 | 440 | 2005 |
| Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors AP Wolanskyj, SM Schwager, RF McClure, DR Larson, A Tefferi Mayo Clinic Proceedings 81 (2), 159-166, 2006 | 431 | 2006 |
| Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis SA Parikh, P Kapoor, L Letendre, S Kumar, AP Wolanskyj Mayo Clinic Proceedings 89 (4), 484-492, 2014 | 342 | 2014 |
| Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients N Gangat, AP Wolanskyj, RF McClure, CY Li, S Schwager, W Wu, ... Leukemia 21 (2), 270-276, 2007 | 272 | 2007 |
| Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patients A Tefferi, EA Wassie, P Guglielmelli, N Gangat, AA Belachew, TL Lasho, ... American journal of hematology 89 (8), E121-E124, 2014 | 258 | 2014 |
| Clinical correlates of JAK2V617F allele burden in essential thrombocythemia J Kittur, RA Knudson, TL Lasho, CM Finke, N Gangat, AP Wolanskyj, ... Cancer 109 (11), 2279-2284, 2007 | 237 | 2007 |
| Milestones and millennials: a perfect pairing—competency-based medical education and the learning preferences of generation Y JR Desy, DA Reed, AP Wolanskyj Mayo Clinic Proceedings 92 (2), 243-250, 2017 | 185 | 2017 |
| FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature A Pardanani, RP Ketterling, CY Li, MM Patnaik, AP Wolanskyj, MA Elliott, ... Leukemia research 30 (8), 965-970, 2006 | 154 | 2006 |
| Concomitant neutrophil JAK2V617F mutation screening and PRV‐1 expression analysis in myeloproliferative disorders and secondary polycythaemia A Tefferi, S Sirhan, TL Lasho, SM Schwager, CY Li, D Dingli, ... British journal of haematology 131 (2), 166-171, 2005 | 152 | 2005 |
| Calreticulin mutations and long-term survival in essential thrombocythemia A Tefferi, EA Wassie, TL Lasho, C Finke, AA Belachew, RP Ketterling, ... Leukemia 28 (12), 2300-2303, 2014 | 150 | 2014 |
| 3023 Mayo Clinic patients with myeloproliferative neoplasms: risk-stratified comparison of survival and outcomes data among disease subgroups N Szuber, M Mudireddy, M Nicolosi, D Penna, RR Vallapureddy, ... Mayo Clinic Proceedings 94 (4), 599-610, 2019 | 143 | 2019 |
| Anemia of chronic disease N Gangat, AP Wolanskyj Seminars in hematology 50 (3), 232-238, 2013 | 139 | 2013 |
| Dynamic phases of peroneal and tibial intraneural ganglia formation: a new dimension added to the unifying articular theory RJ Spinner, KK Amrami, AP Wolanskyj, NM Desy, H Wang, EE Benarroch, ... Neurosurgical Focus 22 (6), 1-12, 2007 | 126 | 2007 |
| The impact of a required longitudinal stress management and resilience training course for first-year medical students LN Dyrbye, TD Shanafelt, L Werner, A Sood, D Satele, AP Wolanskyj Journal of general internal medicine 32, 1309-1314, 2017 | 119 | 2017 |
| Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies N Gangat, AP Wolanskyj, S Schwager, A Tefferi European journal of haematology 82 (5), 350-353, 2009 | 107 | 2009 |
| Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance N Gangat, A Tefferi, G Thanarajasingam, M Patnaik, S Schwager, ... European journal of haematology 83 (1), 17-21, 2009 | 96 | 2009 |
| The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status—clinical correlates in a study of 226 consecutive patients A Pardanani, TL Lasho, CM Finke, N Gangat, AP Wolanskyj, CA Hanson, ... Leukemia 24 (1), 110-114, 2010 | 87 | 2010 |
| Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low‐risk essential thrombocythemia and polycythemia vera N Gangat, AP Wolanskyj, SM Schwager, CA Hanson, A Tefferi Cancer: Interdisciplinary International Journal of the American Cancer …, 2009 | 84 | 2009 |
| Management of extreme thrombocytosis in otherwise low-risk essential thrombocythemia; does number matter? A Tefferi, N Gangat, AP Wolanskyj Blood 108 (7), 2493-2494, 2006 | 84 | 2006 |
